Lexston Life Sciences Is Granted Section 56 Exemption From Health Canada and Embarks on the Development of Portable Technology for Quantification and Traceability of Psilocybe Mushrooms
Lexston Life Sciences (LEXT) received a Section 56 exemption to research psilocybin. It is developing a tool that can rapidly identify and quantify different mushroom compounds such as psilocin, psilocybin, baeocystin, norbaeocystin and aeruginascin.
